Award winning executive search to the private, and investor backed health, care, and life sciences sectors

Health Tech Round Table: A discussion around the challenges and opportunities within HealthTech domestically and globally

Trusted executive search partner to the investment community delivering outstanding leaders for the healthcare and life sciences sectors

Mandates delivered to date

0 %

Delivery rate of all retained mandates

0 %

C-suite appointments are women

0 +

Sub-sectors in healthcare and life sciences supported

Healthcare news, data and analysis
Via Investors in Healthcare

The contract development and manufacturing organization (CDMO) sector is undergoing structural evolution, driven by increased outsourcing, rising complexity, cost pressures and a shift in customer expectations across pharma and medtech. […]

CDMOs: the changing shape of outsourcing

July 11, 2025

Analysis Life Sciences Medtech – Medical Devices and Implants News Pharma

G-Square Healthcare portfolio company, Argos Vétérinaire, a group of independent veterinary clinics across 110 locations in France, has closed a new round of over €100m (US$117m) in unitranche financing with […]

France: Argos Vétérinaire secures €100m in unitranche financing from Adams Street

July 11, 2025

Debt News Veterinary Veterinary Clinics Adams Street Partners

New York listed Merck, known as MSD outside the US and Canada, is to acquire Verona Pharma, a London headquartered biopharmaceutical company focused on respiratory diseases for a total transaction […]

UK: Merck set to acquire Verona Pharma for US$10bn

July 10, 2025

M&A Manufacturing – Specialty Pharma News Pharma Centerview Partners

SK Capital, a New York-based private investment firm focused on the specialty materials, ingredients, and life sciences sectors, has entered into exclusive negotiations with France-based Euronext listed Lisi Group to […]

France: SK Capital in talks to acquire Lisi Group’s medical division

July 10, 2025

Buy Out Life Sciences M&A Medtech – Medical Devices and Implants News

Rhône, a transatlantic, mid-market PE firm, has entered into exclusive discussions to acquire a majority shareholding in two global players in the healthcare and mobility sector: Switzerland-based Invacare, a manufacturer […]

Europe: Rhône enters discussions to combine DHG and Invacare to expand leadership in healthcare mobility sector

July 10, 2025

Buy Out Life Sciences M&A Medtech – Hospital Equipment Medtech – Medical Devices and Implants

Germany-based healthcare investor SHS Capital has acquired a majority stake in Ackermann Instrumente, a Germany-basedmanufacturer of high-quality surgical instruments focused on endoscopy, implantology and general surgery. The investment aims to […]

Germany: SHS Capital aims to build leading medical technology group with acquisition of majority stake in Ackermann

July 10, 2025

Buy Out Life Sciences M&A Medtech – Medical Devices and Implants News

Exponent, a European private equity firm, has announced the final close of its fifth fund, Exponent Private Equity Partners V, with £900m (US$1.225bn) in commitments, some 20% above its target. […]

UK: Exponent announces final close of Fund V at £900m

July 10, 2025

Buy Out Healthcare News Pharma Debevoise & Plimpton

The regulatory data exclusivity and market protection regime in the European Union is changing. When implemented, the proposals will significantly alter the timelines of regulatory exclusivity for medicinal products with […]

EU regulatory exclusivity changes: the increasing importance of patent monopolies for pharma

July 9, 2025

Analysis Legal News Pharma Ben Heller

Companion Spine, a French-American specialist in spine pain-management surgery, has agreed to acquire the Coflex Interlaminar Stabilization device and CoFix Posterior MIS Fusion System implants, Germany-based Paradigm Spine, its subsidiaries […]

Germany: Paradigm Spine returns to Viscogliosi Brothers portfolio through Companion Spine

July 9, 2025

Buy Out Life Sciences M&A Medtech – Medical Devices and Implants News

New York listed Galway-based Medtronic, a global healthcare technology company, has announced the appointment of Chad Spooner as CFO of MiniMed, in advance of its intended separation into a standalone, public company. […]

Ireland: Chad Spooner appointed CFO at MiniMed ahead of split from Medtronic

July 8, 2025

Healthcare Hospitals and Clinics People Chad Spooner Ireland

The University Hospital Basel (USB) is taking over St Claraspital, a private acute care hospital with 210 beds, and other companies from St Clara and Ingenbohl Abbey. Merging the two […]

Switzerland: University Hospital Basel buys Claraspital strengthening university medicine in Basel

July 8, 2025

Healthcare Hospitals and Clinics M&A M&A Deals News

Specialized healthcare investor, Gilde Healthcare, has combined private equity investments in Artinis Medical Systems (Netherlands) and NIRx Medical Technologies (Germany/US), pioneers in functional Near-Infrared Spectroscopy (fNIRS) solutions, establishing a new […]

The Netherlands: Gilde Healthcare combines Artinis and NIRx into a world-leading neuroimaging group

July 8, 2025

Buy Out Life Sciences M&A Medtech – Hospital Equipment Medtech – Medical Devices and Implants

GHO Capital Partners, a European specialist investor in global healthcare, is to acquire a majority holding in EMZ portfolio company, FotoFinder Systems, a Germany-based manufacturer of cutting-edge skin imaging solutions. […]

Germany: GHO to acquire majority holding in FotoFinder Systems

July 8, 2025

Buy Out Cosmetic & Aesthetics Diagnostics Digital Health/Healthtech Healthcare

Mansfield Advisors, a UK-based strategy consulting firm in healthcare, social care, education, life sciences, pharma and veterinary, has announced two promotions to support growth across life sciences, pharma and healthcare. […]

UK: Mansfield Advisors announces promotions to support growth

July 7, 2025

Healthcare Life Sciences News Pharma Arabella Zuckerman

Bertelsmann Investments via its Germany-based pharma tech holding unit cormeo has acquired a majority stake in medicines.ie in a venture that sees cormeo and Irish Pharmaceutical Healthcare Association (IPHA) joining […]

Ireland: cormeo joins forces with IPHA via majority stake acquisition of medicines.ie

July 7, 2025

Buy Out Digital Health/Healthtech Healthcare M&A News

UK-based Essential Pharma, a global pharmaceutical company developing and delivering medicines for patients in niche populations, has appointed Simon Ramsden as CFO and Rob Smith as CTO. Ramsden brings over […]

UK: Essential Pharma appoints CFO and CTO to accelerate growth

July 4, 2025

Articles Manufacturing – Specialty Pharma People Pharma Emma Johnson

Belgium-listed REIT, Cofinimmo, has acquired two healthcare assets under construction in Finland and divested several healthcare assets in Germany and the Netherlands as it continues with its asset rotation plan. […]

Belgium: Cofinimmo acquires two development projects and divests in Germany and the Netherlands

July 4, 2025

Care Homes News Real Estate Social Care Belgium

Aedifica, a Belgium-listed REIT, has invested approximately €26.5m in the development of a state-of-the-art cancer centre in Limerick, Ireland. The property will be let on the basis of a new […]

Ireland: Aedifica expands into new healthcare segment with cancer centre in Limerick

July 4, 2025

Healthcare Hospitals and Clinics News Real Estate Aedifica

EQT Healthcare Growth (EQT) has agreed to acquire a majority stake in Sweden-headquartered Europa Biosite, a distributor of high-quality research-use-only (RUO) life science reagents, chemicals, and biological substances used in […]

Sweden: EQT Healthcare Growth acquires majority stake in Europa Biosite from Adelis

July 3, 2025

Buy Out M&A News Pharma Services – CRO/CMO/CDMO

SIX-Swiss listed Galenica, a Switzerland-based international pharmaceutical and logistics company, is entering the diagnostics business with the acquisition of Diagnostics Group (Labor Team Group), a Switzerland-based operator of medical laboratories […]

Switzerland: Galenica enters diagnostics market with acquisition of Labor Team Group

July 3, 2025

Diagnostics Healthcare M&A News Alain M Cahen

Joe Hardy has returned to Knight Frank as a partner focussing on Healthcare Valuation & Advisory, working alongside Kieren Cole. Hardy is an experienced Chartered Surveyor with 20-plus years in […]

UK: Joe Hardy returns to Knight Frank as partner

July 3, 2025

Healthcare News People Real Estate Social Care

The boards of an SPV of KKR (Bidco) and Spectris, a UK-listed supplier of precision instrumentation and controls, have reached agreement on the terms of a recommended cash acquisition of […]

UK: KKR and Spectris agree terms on £4.1bn cash offer

July 2, 2025

Buy Out M&A News Pharma Public Equity

Specialist Nordic social infrastructure asset manager Northern Horizon has expanded its healthcare portfolio with the acquisition of a care home under development in Espoo, Finland. The property is being developed […]

Finland: Northern Horizon’s evergreen fund, ACSIF, acquires care home in Finland

July 2, 2025

Care Homes M&A M&A Deals News Real Estate

Fresh from news of Bridgepoint acquiring a significant controlling stake in Stockholm-based Safe Life comes the announcement that the global leader in the distribution of automated external defibrillators (AEDs) has […]

Spain: Safe Life enters Spanish AED market with acquisition of Salvavidas Cardio

July 2, 2025

Life Sciences M&A Medtech – Medical Devices and Implants News Bridgepoint

Swedish investment firm, Fidelio Capital, has acquired a majority stake in Denmark-based Alphalyse, a specialist CRO that has developed GMP‑validated liquid‑chromatography mass‑spectrometry (LC‑MS) assays for host‑cell‑protein (HCP) impurity testing in […]

Denmark: Fidelio Capital partners with Alphalyse to accelerate global roll-out of LC-MS host cell protein analytics

July 2, 2025

M&A News Pharma Services – CRO/CMO/CDMO Alphalyse

Our Sectors

We are experts at what we do

Healthcare

Social Care

Biopharmaceuticals

Medical Technologies

Enabling Services

01 Our People

A dedicated team of executive search experts, delivering for you

The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.

Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.

Our Team

Meet the Team

Adam Carter

Meet the Team

Luke Osborne

Meet the Team

Abigail Badà

Meet the Team

Sam Leighton-Smith BA Hons

02 Expertise

Unearthing rare talent, that drive successful exits

Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.

Expertise

Board

Expertise

Executive Leadership

Expertise

Finance & Commercial

Expertise

People & Culture

03 Our Approach

Tailoring our offering,
to provide a bespoke service

Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.

Our Approach

A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors

What our clients say

“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”

Outcomes First Group – Chair

“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”

Hengrui Therapeutics – VP, Head Biological Drug Discovery

“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”

The Professional Footballers Association (PFA) – Chief Executive Officer

“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”

Priory Group – Chief Executive Officer

“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”

Priory – Independent Non-Executive Director

“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”

AniCura – Group Chief Operating Officer

“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building. Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”

Renaiss Health – Chief Executive Officer

“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”

One Nucleus – Director

“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”

Melrose Education – Chair & CEO

“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”

Schoen Clinic – Member of Group Executive